Showing results (441-450 of 458) with videos related to
Sort By:
Pageof 46
Biorxiv : the Preprint Server for Biology|December 18, 2023
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastomaAmber K Weiner, Alexander B Radaoui, Matthew Tsang, et al.Cancer Discovery|July 31, 2024
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister CellsLiron D Grossmann, Chia-Hui Chen, Yasin Uzun, et al.Cancer Discovery|April 13, 2026
IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancersHai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang, et al.Cancer Cell|October 25, 2024
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastomaAmber K Hamilton, Alexander B Radaoui, Matthew Tsang, et al.Nature Communications|June 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivityIsabel Soria-Bretones, Matias Casás-Selves, Minu Samanta, et al.Cancer Cell|December 31, 2021
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicitySabine Heitzeneder, Kristopher R Bosse, Zhongyu Zhu, et al.Pediatric Blood & Cancer|June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy ForumSteven G DuBois, Lucas Moreno, John Anderson, et al.Biorxiv : the Preprint Server for Biology|July 19, 2024
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.Gigascience|September 2, 2025
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.Cancer Discovery|April 4, 2024
The Virtual ChildRichard J Gilbertson, Sam Behjati, Anna-Lisa Böttcher, et al.Pageof 46